Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Joseph Gligorov and Jean-Philippe Spano.
Joseph Gligorov
Connection Strength
0.957
Jean-Philippe Spano
  1. Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients. Ann Oncol. 2021 08; 32(8):1051-1053.
    View in: PubMed
    Score: 0.236
  2. Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use? Eur J Cancer. 2020 09; 136:1-3.
    View in: PubMed
    Score: 0.222
  3. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer. 2020 08; 135:130-146.
    View in: PubMed
    Score: 0.222
  4. [COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]. Bull Cancer. 2020 05; 107(5):528-537.
    View in: PubMed
    Score: 0.219
  5. High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers. Ann Oncol. 2021 10; 32(10):1294-1295.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.